Gene
|
Chromosome
|
Chen, 2005 [41]
|
Lenhard, 2005 [23]
|
Abbaszadegan, 2007 [42]
|
Itzkowitz, 2008 [39]
|
Wang, 2008 [43]
|
Baek, 2009 [44]
|
Hellebrekers, 2009 [37]
|
Kim, 2009 [24]
|
Nagasaka, 2009 [45]
|
Chang, 2010 [46]
|
Kalimutho, 2011 [33]
|
Tang, 2011 [47]
|
Guo, 2013 [25]
|
Zhang, 2013 [48]
|
He, 2014 [26]
|
Lu, 2014 [49]
|
Wu, 2014 [36]
|
Zhang, 2014 [50]
|
Li, 2015 [27]
|
Xiao, 2015 [32]
|
Kriegshäuser, 2017 [38]
|
Niu, 2017 [51]
|
Oh, 2017 [35]
|
Park, 2017 [34]
|
Yang, 2017 [52]
|
Han, 2019 [28]
|
Liu, 2019 [40]
|
Report frequency
|
Significant resultsa
|
---|
miR-34a
|
1
| | | | | | | | | | | | | | | | | ◊↑ | | | | | | | | | | |
1
|
1
|
ITGA4
|
2
| | | | | | | | | |
□↑
| | | | | | | | | | | | | | | | | ◊↑ |
2
|
2
|
TLX2
|
2
| | | | | | | | | | | | | | | | | | | | | | | | | | |
∆↑
|
1
|
1
|
MLH1
|
3
| | | | | |
□↑
| | | | | | | | | | | | | | | | | | | | | |
1
|
1
|
BMP3
|
4
| | | | | | | | | | | | | | | | | | | | | | | |
□↑
| | | |
1
|
1
|
SFRP2
|
4
| | | | | ◊↑ | | | | ◊↑ |
□↑
| | ◊↑ | | | |
∆↑
| |
∆↑
| | | ◊↑ | | |
□↑
| | | |
10
|
10
|
SNCA
|
4
| | | | | | | | | | | | | | | | | | | ◊↑ | | | | | | ◊↑ | | |
2
|
2
|
OSMR
|
5
| | | | | | | | ◊↑ | | | | | | | | | | | | | | | | | | | |
1
|
1
|
TFPI2
|
7
| | | | | | | | | | | | | | | | | | | | | | | |
□↑
| | | |
1
|
1
|
GATA4
|
8
| | | | | | | ◊↑ | | | | | | | | |
∆↑
| | | | | | | | | | | |
3
|
3
|
SDC2
|
8
| | | | | | | | | | | | | | | | | | | | | | ◊↑ | ◊↑ | | | ◊↑ | |
3
|
3
|
CDKN2A
|
9
| | | ◊↑ | | | | | | |
□↑
| | | | | | | | | | | | | | | | | |
2
|
2
|
MGMT
|
10
| | | | | |
□↑
| | | | | | | | | | | | | | | | | | | | | |
1
|
1
|
VIM
|
10
| ◊↑ | | | ◊↑ | |
□↑
| | | | | | | | | |
∆↑
| | | | | | | | | | | |
5
|
5
|
miR-34b/c
|
11
| | | | | | | | | | | ◊↑ | | | | | | ◊↑ | | | | | | | | | | |
2
|
2
|
WIF-1
|
12
| | | | | | | | | | | | | | | | | |
∆↑
| | | | | | | | | |
2
|
2
|
COL4A1
|
13
| | | | | | | | | | | | | | | | | | | | | | | | | | | ◊↑ |
1
|
1
|
COL4A2
|
13
| | | | | | | | | | | | | | | | | | | | | | | | | | |
∆↑
|
1
|
1
|
ING1
|
13
| | | | | | | | | | | | | | | ◊↑ | | | | | | | | | | | | |
1
|
1
|
SPART
|
13
| | | | | | | | | | | | | | ◊↑ | | | | | | | | | | | | | |
1
|
1
|
FBN1
|
15
| | | | | | | | | | | | | ◊↑ | | | | | | ◊↑ | | | | | | | | |
2
|
2
|
NDRG4
|
16
| | | | | | | | | | | | | | | |
∆↑
| | | | ◊√ | | | |
□↑
| | | |
4
|
3
|
HIC1
|
17
| | ◊↑ | | | | | | | | | | | | | | | | | | | | | | | | | |
1
|
1
|
GATA5
|
20
| | | | | | | | | | | | | | | |
∆↑
| | | | | | | | | | | |
2
|
2
|
RASSF2
|
20
| | | | | | | | | ◊↑ | | | | | | | | | | | | | | | | | | |
1
|
1
|
- a Frequency of significant results for association of methylation status of gene with overall CRC risk
- ◊ Represents markers evaluated only individually
- □ Represents markers evaluated only in a panel
- ∆ Represents markers evaluated both individually and in a panel
- ↑ Represents hypermethylated marker in CRC cases compared to controls
- √ Represents no p-value reported or could be calculated